Risperidone
- Product NDC
- 50458-591
- 11-digit product format
- 504580591
- Labeler code
- 50458
- Product ID
- 50458-591_fd12f36e-67f4-11e9-b194-e90b0199106d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- risperidone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Janssen Pharmaceutical, Inc.
- Application
- NDA020272
- Marketing category
- NDA
- Marketing start
- 1993-12-29
- Marketing end
- 2020-08-31
- Substance
- RISPERIDONE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50458-591-10 | Risperidone | 10 in 1 BOX, UNIT-DOSE | TABLET | 10 | | 33 |
| 50458-591-10 | Risperidone | 10 in 1 BLISTER PACK | TABLET | 10 | | 33 |
| 50458-591-50 | Risperidone | 500 in 1 BOTTLE | TABLET | 500 | | 33 |
| 50458-591-60 | Risperidone | 60 in 1 BOTTLE | TABLET | 60 | | 33 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| risperidone | ACTIVE INGREDIENT | L6UH7ZF8HC | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| risperidone | ACTIVE MOIETY | L6UH7ZF8HC | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| Aluminum Oxide | INACTIVE INGREDIENT | LMI26O6933 | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| anhydrous lactose | INACTIVE INGREDIENT | 3SY5LH9PMK | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| benzoic acid | INACTIVE INGREDIENT | 8SKN0B0MIM | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| carbomer homopolymer type c (allyl pentaerythritol crosslinked) | INACTIVE INGREDIENT | 4Q93RCW27E | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| D&C Yellow No. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| FD&C Blue No. 2 | INACTIVE INGREDIENT | L06K8R7DQK | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| FD&C Yellow No. 6 | INACTIVE INGREDIENT | H77VEI93A8 | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| ferric oxide yellow | INACTIVE INGREDIENT | EX438O2MRT | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| glycine | INACTIVE INGREDIENT | TE7660XO1C | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| peppermint oil | INACTIVE INGREDIENT | AV092KU4JH | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| starch, corn | INACTIVE INGREDIENT | O8232NY3SJ | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| tartaric acid | INACTIVE INGREDIENT | W4888I119H | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
| xanthan gum | INACTIVE INGREDIENT | TTV12P4NEE | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 10 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50458-591 | RISPERIDONE TABLET RISPERIDONE SOLUTION RISPERIDONE M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING [JANSSEN PHARMACEUTICAL, INC.] | 32 | Legacy NDC, 4 package rows | 20250302_701e1cd8-2868-4d29-85a9-a2212c88165f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 50458-591-10 | 50458059110 | 10 in 1 BOX, UNIT-DOSE | Historical |
| 50458-591-50 | 50458059150 | 500 in 1 BOTTLE | Historical |
| 50458-591-60 | 50458059160 | 60 in 1 BOTTLE | Historical |